Pros of the Eversence CGM:
> I suppose the main advantage afforded by Eversense is that there is no need to “change” the sensor on a regular basis, as is the case with all other CGM systems.
In the US, the sensor is approved for 3 months of continuous use, and the European version (scheduled to hit the US market in the next year or two) is good for 6 months.
What this means is that there are no “warmup” times other than the day the sensor is first inserted. I believe this type of true continuity makes Eversense an ideal CGM to use with hybrid closed loop systems which depend on sensor data to function.
> If you’re concerned about having something in your body, don’t be. The sensor is made of bio-compatible materials that cause no allergic or immunologic responses. And because there is no discernable metal in the sensor, it need not be removed during standard medical procedures.
> The accuracy of the sensor is quite good. Its MARD (mean absolute relative difference) compared to laboratory glucose values is just below 9%, which makes it the most accurate CGM on the market. By comparison, Dexcom is just below 10%; Medtronic and Abbott Libre remain in double-digits.
> The smart transmitter is also appealing. I don’t usually have my phone on me when running or playing basketball, so I found the high/low vibrations produced by the transmitter to be useful.
> The silicone-based transmitter adhesive holds it in place very nicely with a very low incidence of skin irritation. And by the way, the transmitter can be removed and replaced without losing any data.
> The Eversense cellphone app is relatively easy to use. It generates useful reports and allows for variable alert settings. Being able to see up to 90 days’ historical data, including trend graphs, right on screen is unique to this system.